76 related articles for article (PubMed ID: 23760770)
1. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.
Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM
Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083
[TBL] [Abstract][Full Text] [Related]
2. Dermaseptin B2 bioactive gene's potential for anticancer and anti-proliferative effect is linked to the regulation of the BAX/BBC3/AKT pathway.
Nasirabadi FK; Doosti A
Med Oncol; 2024 May; 41(6):162. PubMed ID: 38767753
[TBL] [Abstract][Full Text] [Related]
3. RNA disruption is associated with response to multiple classes of chemotherapy drugs in tumor cell lines.
Narendrula R; Mispel-Beyer K; Guo B; Parissenti AM; Pritzker LB; Pritzker K; Masilamani T; Wang X; Lannér C
BMC Cancer; 2016 Feb; 16():146. PubMed ID: 26911141
[TBL] [Abstract][Full Text] [Related]
4. The effect of "NutramilTM Complex," food for special medical purpose, on breast and prostate carcinoma cells.
Koronowicz AA; Drozdowska M; Wielgos B; Piasna-Słupecka E; Domagała D; Dulińska-Litewka J; Leszczyńska T
PLoS One; 2018; 13(2):e0192860. PubMed ID: 29444163
[TBL] [Abstract][Full Text] [Related]
5. Fbxo45 joins the 'Par-4'ty in controlling apoptosis of cancer cells.
Wang Z; Wei W
Cell Death Differ; 2014 Oct; 21(10):1508-10. PubMed ID: 25196972
[No Abstract] [Full Text] [Related]
6. Caspase-8-mediated PAR-4 cleavage is required for TNFα-induced apoptosis.
Treude F; Kappes F; Fahrenkamp D; Müller-Newen G; Dajas-Bailador F; Krämer OH; Lüscher B; Hartkamp J
Oncotarget; 2014 May; 5(10):2988-98. PubMed ID: 24931006
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 as a potential key regulator for mediating apoptosis in oropharyngeal cancer using cyclophosphamide and all-trans retinoic acid.
Haggagy MG; Ahmed LA; Sharaky M; Elhefnawi MM; Omran MM
Sci Rep; 2024 Jan; 14(1):41. PubMed ID: 38167952
[TBL] [Abstract][Full Text] [Related]
8. CircHSPG2 absence weakens hypoxia-induced dysfunction in cardiomyocytes by targeting the miR-25-3p/PAWR axis.
Zhao Y; Wang S; Liu S; Yan Q; Li Y; Liu Y
Cardiovasc Diagn Ther; 2022 Oct; 12(5):589-602. PubMed ID: 36329956
[TBL] [Abstract][Full Text] [Related]
9. Arylquin 1 (Potent Par-4 Secretagogue) Inhibits Tumor Progression and Induces Apoptosis in Colon Cancer Cells.
Chen YT; Tseng TT; Tsai HP; Huang MY
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628455
[TBL] [Abstract][Full Text] [Related]
10. Prostate apoptosis response-4 and tumor suppression: it's not just about apoptosis anymore.
Cheratta AR; Thayyullathil F; Pallichankandy S; Subburayan K; Alakkal A; Galadari S
Cell Death Dis; 2021 Jan; 12(1):47. PubMed ID: 33414404
[TBL] [Abstract][Full Text] [Related]
11. Expression of PAWR predicts prognosis of ovarian cancer.
Tan J; Tao K; Zheng X; Liu D; Ma D; Gao Q
Cancer Cell Int; 2020 Dec; 20(1):598. PubMed ID: 33317551
[TBL] [Abstract][Full Text] [Related]
12. Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity.
de Bessa Garcia SA; Pavanelli AC; Cruz E Melo N; Nagai MA
Int J Mol Med; 2017 Apr; 39(4):809-818. PubMed ID: 28259909
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance and targeted therapies in ovarian and endometrial cancers.
Brasseur K; Gévry N; Asselin E
Oncotarget; 2017 Jan; 8(3):4008-4042. PubMed ID: 28008141
[TBL] [Abstract][Full Text] [Related]
14. miR-107 Promotes Proliferation and Inhibits Apoptosis of Colon Cancer Cells by Targeting Prostate Apoptosis Response-4 (Par4).
Liu F; Liu S; Ai F; Zhang D; Xiao Z; Nie X; Fu Y
Oncol Res; 2017 Jul; 25(6):967-974. PubMed ID: 27938501
[TBL] [Abstract][Full Text] [Related]
15. Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells.
Brasseur K; Fabi F; Adam P; Parent S; Lessard L; Asselin E
Oncotarget; 2016 Jun; 7(24):36971-36987. PubMed ID: 27175591
[TBL] [Abstract][Full Text] [Related]
16. Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning.
Dorman SN; Baranova K; Knoll JH; Urquhart BL; Mariani G; Carcangiu ML; Rogan PK
Mol Oncol; 2016 Jan; 10(1):85-100. PubMed ID: 26372358
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.
Liu Y; Gilbert MR; Kyprianou N; Rangnekar VM; Horbinski C
Acta Neuropathol; 2014 Nov; 128(5):723-32. PubMed ID: 25135281
[TBL] [Abstract][Full Text] [Related]
18. Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells.
Pereira MC; de Bessa-Garcia SA; Burikhanov R; Pavanelli AC; Antunes L; Rangnekar VM; Nagai MA
Int J Oncol; 2013 Aug; 43(2):531-8. PubMed ID: 23760770
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
